Digital RESI March 22-24 Agenda


Digital RESI March 22-24, 2022 Agenda
All Day Partnering
10AM ESTIPC Session #1Mental & Behavioral Health PanelIPC Session #8
IPC Session #5
11aM ESTEarly Stage Therapeutics PanelAge-Tech Devices PanelPrecision Medicine Panel
12PM ESTFirst Republic Bank
Burns & Levinson
1PM ESTIPC Session #2IPC Session #6Cell & Gene Therapy Panel
IPC Session #9
2PM ESTLongevity, Health & Wellness PanelMedtech Strategics PanelDefining AI Investment Panel
3PM ESTSeed Funds PanelAI Drug Discovery & Development PanelIPC Session #10
IPC Session #3
4PM ESTTales from the Road: AI Innovators on their Fundraising JourneyTales from the Road: Biotech and MedTech Innovators on their Fundraising JourneyTales from the Road: Age-Tech Innovators on their Fundraising Journey
5PM ESTIPC Session #4IPC Session #7IPC Session #11

About RESI

The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.

RESI Conference Series 2022

Digital RESI JPM, January 11-13
Digital RESI, March 22-24
RESI San Diego, June 14-16
RESI Boston, September 20-22
RESI Asia, November 15-17

Who Should Attend

RESI is committed to facilitating conversations that spark early-stage deals in across drugs, devices, diagnostics, and digital health that save lives and change the world through healthcare innovation. To advance the most successful deals, all major players, including both buyers and sellers, are saved a seat at the table. RESI attracts incubators, tech transfer offices, universities, hospitals, research labs and their constituents getting on the radar of investors and channel partners. Biotech, medtech, diagnostics, and digital health companies source global investors and strategic partners, create relationships, and pitch to secure funding from Seed to Series B.

300-450+ Investors & Strategic Partners

Investors get a front-row seat to emerging early-stage companies, with direct insight into product pipelines, licensing opportunities, financing rounds, technologies, licensing deals, and management details in order to find the best fit for their theme.

300-450+ Start-Ups & Fundraising Executives

Life science and healthcare fundraising CEOs gain access to investors and strategic partners actively seeking opportunities that match their product set and stage of development through a match-based partnering system, pitch session opportunities, and industry expert panels.

100-200+ Service Providers

Deal-making is not just a two-way street. The early-stage arena can be challenging to navigate without the help of law firms, broker-dealers, CROs/CMOs, and consulting services to assist in bringing a bright prospect to market.

What to Expect

Life Science Nation (LSN) was founded to help move science forward and be part of the change that is coming to the life science domain. Capital is the missing ingredient holding back the advancement of life science today. LSN remains dedicated to helping emerging life science companies identify and connect with early-stage investors, and our story has just begun.

Contact Us

Stay Up-to-Date with Weekly Newsletters

Stay up-to-date with weekly industry insights, expert interviews, event announcements, and active investor mandates with our three newsletters. Click the logo below to subscribe!